JUBLINGREA.BOBSE
Jubilant Ingrevia Limited
₹650.75
ListedMar 19, 2021
SectorBasic Materials
IndustrySpecialty Chemicals
CountryIndia
Employees-
State-| CityNoida| AddressPlot 1A, Sector 16A| Phone91 12 0436 1000
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
37.2
?
Div. Rate
₹5.00
?
Div. Yield
0.77%
?
Payout Ratio
28.56%
?
Max Consec. Div. Years
5 years
?
Longest Consec. Div.
4 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.00
?
Div. Growth Rate
0.00%
?
Score
80

Dividend History

Historical dividend payments by ex-dividend date.

Feb 10, 2026
₹ 2.5000
Jul 25, 2025
₹ 2.5000
Feb 3, 2025
₹ 2.5000
Aug 2, 2024
₹ 2.5000
Feb 9, 2024
₹ 2.5000
Aug 10, 2023
₹ 2.5000
Feb 10, 2023
₹ 2.5000
Aug 23, 2022
₹ 2.5000
Feb 10, 2022
₹ 2.5000
Aug 5, 2021
₹ 0.3500

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!